LPA

Lipoprotein(a) (Lp(a)), is an inherited cholesterol-related risk factor for heart disease. This clinical research study is evaluating

Enrollment Status

Patients are enrolling on a dialysis patient basis

About This Study Title

Lipoprotein(a) (Lp(a)), is an inherited cholesterol-related risk factor for heart disease. This clinical research study is evaluating an investigational treatment for individuals with elevated Lipoprotein(a). Every study is conducted according to a carefully designed protocol with participant safety, quality, and regulatory compliance at th

Who May Qualify

You may be eligible to participate if you:

  • Are between the ages of 10 to 65
  • Have been diagnosed with elevated Lp(a)
  • Are currently receiving care in an intensive care or hospital setting

Additional eligibility criteria apply.

What Participation Involves

Participation includes:

  • Study related treatments or standard of care
  • Regular assessments and monitoring
  • Collection of study-related data and samples

All study-related care is provided at no cost to participants.

Why Participate?

By participating in this study, you may help advance medical research and contribute to the development of new treatments for Lp(a) and future patients. 

Interested in This Study?

Fill out the form below and a member of our research team will contact you.

Your information is secure and will only be used by our research team.
Or

Contact Our Team

Prefer to speak with someone now?

Mon – Fri, 8:00 AM – 5:00 PM ET

Speak With Our Team

Have questions about this study or want to learn more?

Scroll to Top